Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xylem Inc. Director's Dealing 2011

Nov 3, 2011

30109_dirs_2011-11-03_4012f890-0ccb-43c3-81ee-84593840196e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01

Reporting Person: HAMRE JOHN J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-01 Common Stock A 5265 $0.00 Acquired 21994 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-01 Stock Option (Right to Buy) $19.40 A 3560 Acquired 2012-05-07 Common Stock (3560) Direct
2011-11-01 Stock Option (Right to Buy) $17.35 A 2420 Acquired 2013-01-04 Common Stock (2420) Direct
2011-11-01 Stock Option (Right to Buy) $21.03 A 2480 Acquired 2014-02-02 Common Stock (2480) Direct
2011-11-01 Stock Option (Right to Buy) $25.53 A 2140 Acquired 2012-03-08 Common Stock (2140) Direct
2011-11-01 Stock Option (Right to Buy) $29.57 A 3040 Acquired 2013-03-06 Common Stock (3040) Direct
2011-11-01 Stock Option (Right to Buy) $32.56 A 2700 Acquired 2014-03-07 Common Stock (2700) Direct
2011-11-01 Stock Option (Right to Buy) $29.81 A 2960 Acquired 2015-03-10 Common Stock (2960) Direct
2011-11-01 Stock Option (Right to Buy) $18.63 A 3970 Acquired 2016-03-05 Common Stock (3970) Direct
2011-11-01 Stock Option (Right to Buy) $30.03 A 2860 Acquired 2020-03-05 Common Stock (2860) Direct
2011-11-01 Phantom Stock $ A 1840 Acquired Common Stock (1840) Direct

Footnotes

F1: These options are fully vested and exercisable.

F2: 2,647 options are vested and exercisable and the remainder will vest on March 5, 2012.

F3: 954 options are vested and exercisable and the remainder will vest in two equal annual installments beginning on March 5, 2012.

F4: Each share of phantom stock represents the right to receive the cash value of 1 share of Xylem Inc. common stock.

F5: Credited shares of phantom stock are payable in cash following the director's termination of service on the board of directors or a date selected by the director.